United States · FDA National Drug Code directory
Paliperidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69367-434_10e430a8-a911-4b08-8efb-694387c50531
- Product NDC
- 69367-434
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Paliperidone
- Labeler
- Westminster Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251209
- Source listing expiry
- 20271231
Source-listed ingredients
- PALIPERIDONE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-434-30) · 69367-434-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →